跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Nagelin (Reformulated) - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Nagelin (Reformulated)
Approved
STANDARD
Nagelin (Reformulated)
La Croesus Pharma, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
70786592a9f8254d
Company
La Croesus Pharma, Inc.
Type
Standard
Approval Details
Approval Id
70786592a9f8254d
Drug Approval Philippines Name
Nagelin (Reformulated)
Product Name
Nagelin (Reformulated)
Registration Number
DR-XY42858
Brand Name
Nagelin (Reformulated)
Generic Name
Paracetamol + Phenylephrine HCl + Chlorpheniramine Maleate
Dosage Form
Capsule
Dosage Strength
325 mg/25mg/2mg
Manufacturer
La Croesus Pharma, Inc.
Trader
IAE Pharmaceuticals Corporation
Issuance Date
24 October 2023
Expiry Date
23 October 2028
Pharmacologic Category
Analgesic/Antipyretic/Decongestant/Antihistamine
Classification
Over-The-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
70786592a9f8254d
Type
Standard
Back to Philippines FDA Approvals